Bipolar Disorder Clinical Trial
— MoBOfficial title:
The Management of My Bipolarity Intervention on the Combined Use of Technology and Face to Face Education on the Empowerment of Ill Health Self-management Skills in Adults With a Bipolar Disorder
Verified date | November 2020 |
Source | Cyprus University of Technology |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The Management of my Bipolarity study aims to develop an educational intervention (MoB EI) on the combined use of technology and face to face education on the empowerment of ill health self-management skills in adults with bipolar disorder. The MoB EI will be developed according to qualitative data on patients' educational needs and relevant literature. The effectiveness of acquired knowledge and self-management skills will be assessed according to the degree of a) cognitive functioning, b) impulse control, c) adherence to pharmacotherapy, d) relapse prevention, d) improvement of quality of life of participants.
Status | Active, not recruiting |
Enrollment | 80 |
Est. completion date | December 31, 2022 |
Est. primary completion date | December 31, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion criteria: 1. Clinical diagnosis based on DSM-5 for BD type I and II. 2. Age between 18 and 65. 3. Signed informed consent. 4. Stabilized mood status at the beginning of the MoB F2F intervention based on clinical assessment, conducted by the primary investigator (AH). 5. Experience of the illness of at least one year based on reported medical record. 6. Adequate awareness of the illness, based on the following guide: (a) are you aware of the reason(s) you are using mental health services/ under medication? and (b) are you aware of the aim of the educational intervention in which you may participate? Exclusion criteria: 1. Intellectual disability (IQ<70), based on the Wechsler Adult Intelligence Scale (WAIS). 2. Brain damage (e.g, following a stroke), based on diagnostic tests. 3. Acute phase of the illness which requires hospitalization. 4. Acute phase of the illness, based on clinical assessment, as well as the Young Mania Rating Scale (YMRS) and/or Beck's Depression Inventory (BDI) tools. 5. Substance use problems at the beginning of this stage according to the Alcohol Use Disorders Identification Test (AUDIT) and Drug Use Disorders Identification Test (DUDIT) tools. |
Country | Name | City | State |
---|---|---|---|
Cyprus | Cyprus University of Technology | Limassol |
Lead Sponsor | Collaborator |
---|---|
Cyprus University of Technology |
Cyprus,
21. Hatzioannou A, Papastavrou E, Chatzittofis A, Karanikola M. Exploration of the effectiveness of structured education in empowering people with Bipolar Disorder. Nursing Care & Research 2020;55:246-274.
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Bipolar disease patients educational needs | Qualitative measures: 1. Knowledge/ mental health literacy on present medical condition (measurement tool [MT]/ Open-ended question: Please tell us, what do you know about your mental health condition/ BD?) 2. Knowledge gap regarding BD (MT/ Open ended question: Please describe what you would like to know about bipolar disorders).
3. Topics to be covered (MT/ Open ended question: Please describe in what way/topics you would like to be educated on bipolar disorders/to increase your knowledge about bipolar disorders? 4. Educational and feasibility expectations (MT/ Open-ended questions: a. Please describe your expectations from an educational program regarding the impact on your everyday living b. How you would like this program to be implemented one on one or in a group? C. How long would you like the program to last? 5. e-Health literacy (MT/ Open ended question: What is your level of engagement with the Internet?) |
6 months | |
Primary | Degree of self-perceived quality of life as measured by the total score in the scale "World Health Organization Quality of Life Assessment". | The scale "World Health Organization Quality of Life Assessment" is a 1-5 Likert type scale including 26 items. The minimum score in the scale is 26 and the maximun is 130.
Higher scores indicate a better outcome. |
18 months | |
Primary | Level of knowledge regarding BD, as measured by the total score in the scale "Bipolar Disorder Knowledge Scale". | The "Bipolar Disorder Knowledge Scale" is a 25-item true-false scale. The scale assesses knowledge of BD with items targeting diagnosis, etiology, disease course, symptoms, treatment, and life impact. The ration of "true" to "false" responses is assessed. Higher percentage values indicate a better outcome. | 18 months | |
Primary | Degree of ability to control impulses, as measured by the total score in the scale "YOUNG MANIA RATING SCALE " (YMRS) . | The "YMRS" is a 0-4 likert scale, including 11 items. The total score of the scale ranges from 0 to 44. The lower the total score the better the outcome. | 18 months | |
Primary | Degree of adherence to pharmacotherapy, as measured by the total score in the scale "Drug Attitude Inventory" (DAI). | The "DAI" is a 30 item "true-false" scale.The ration of "true" to "false" responses is assessed. Higher percentage values indicate a better outcome. | 18 months | |
Primary | Degree of dysfunctional attitudes towards substance use as measured by the total score in the scale "Drug Use Disorders Identification Test" (DUDIT). | The scale DUDIT is a 1-5 Likert, 11-item scale (scale total score range: 1-55) . The lower the total score the better the outcome.
Lower scores indicate a better outcome. |
18 months | |
Primary | Degree of dysfunctional attitudes towards alcohol as measured by the total score in the scale "Alcohol Use Disorders Identification Test" (AUDIT). | The AUDIT scale is a 0-4 Likert, 10-item scale (scale total score range: 0-40) .
Lower scores indicate a better outcome. |
18 months | |
Primary | Frequency of relapses, as measured by the number of hospitalizations after the completion of the face to face intervention. | The number of hospitalizations will be measured as the sum of the individual hospitalizations in a high security psychaitric hospital.
The lower the number of the frequency the better the outcome. |
Two years following the end of the face tot face educational intervention. | |
Primary | Reduced duration of relapses, as measured by the duration of inpatient hospitalizations in days after the completion of the face to face intervention. | The duration of inpatient hospitalizations will be measured as the sum of the days of hospitalization in high security psychaitric hospitals.
The lower the duration in days of the hospitalization the better the outcome. |
Two years following the end of the face to face educational intervention. | |
Primary | Degree of feasibility of the digital platform, as measured by users' qualitative feedback on the following open-ended question: "Please tell us, what was your experience with the MoB DP use? | The more positive the described experience the better the outcome. | 6 months | |
Primary | Degree of feasibility of the digital platform, as measured by the users' qualitative feedback on the impact of the MoB DP on their life based on the following open-ended question: "Please tell us, what was the impact of the MoB DP use on your life?" | The more positive the described impact of the MoB DP on users' life the better the outcome. | 6 months | |
Primary | Degree of feasibility of the digital platform, measured by users' feedback on the impact of the platform on their self-management skills based on the question "What was the impact of the platform on your ill health self-management skills?" | The more positive the described impact of the digital platform on users' ill health self-management skills the better the outcome. | 6 months | |
Primary | Degree of feasibility of the digital platform, as measured by users' self-reported degree of satisfaction on MoB DP by the total score on the scale "Users' Satisfaction Scale" (USS). | The USS is 1-3 Likert scale (low;moderate/accepted; high), which includes 6 items, assessing users' perceptions about overall experienced satisfaction (item1); utility according to their present medical condition (item 2); feasibility on daily usage (item 3); technical difficulties experienced (item 4); improvement of BD self-management skills (item 5); improvement of BD knowledge (item 6).
The total score of the USS ranges between 6- 18. The higher the total score the better the outcome. |
6 months | |
Secondary | Description of the topics of the MoB educational intervention through a qualitative measure. | Measurement tool: Open-ended question "Please describe on which topics you would like to be aducated or increase your knowledge on BD with focus on therapeutic issues, pathophysiology, well-being and patients' rights." | 6 months | |
Secondary | Description of the mode of the MoB educational intervention through a qualitative measure. | Measurement tool: Open-ended question "Please describe the mode through which you would like to recieve information with special focus on the duration, number of sessions and duration of each session of the intervention" | 6 months | |
Secondary | Description of the different modes of the MoB educational intervention through a qualitative measure. | Measurement tool: Open-ended question "Please describe the mode through which you would like to recieve information with focus on personal or group sessions, face-to-face or via internet sessions " | 6 months | |
Secondary | Description of the MoB DP technology-based intervention through a qualitative measure. | Measurement tool: Open-ended question "What is your preferences regarding a technology-based educational intervention on BD with focus on the topics to be included, on the information provision mode (interactive or not), and access modes (tablet, mobile, personal computer)?" | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT02855762 -
Targeting the Microbiome to Improve Clinical Outcomes in Bipolar Disorder
|
N/A | |
Recruiting |
NCT05915013 -
Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
|
Phase 1 | |
Recruiting |
NCT05206747 -
Ottawa Sunglasses at Night for Mania Study
|
N/A | |
Completed |
NCT02513654 -
Pharmacokinetics, Safety and Tolerability of Repeat Dosing Lamotrigine in Healthy Chinese Subjects
|
Phase 1 | |
Recruiting |
NCT06313918 -
Exercise Therapy in Mental Disorders-study
|
N/A | |
Completed |
NCT02304432 -
Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine
|
Early Phase 1 | |
Recruiting |
NCT06197048 -
Effect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psychosis or Bipolar Affective Disorder
|
N/A | |
Completed |
NCT03497663 -
VIA Family - Family Based Early Intervention Versus Treatment as Usual
|
N/A | |
Completed |
NCT04284813 -
Families With Substance Use and Psychosis: A Pilot Study
|
N/A | |
Completed |
NCT02212041 -
Electronic Cigarettes in Smokers With Mental Illness
|
N/A | |
Recruiting |
NCT05030272 -
Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings
|
N/A | |
Recruiting |
NCT04298450 -
ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention
|
N/A | |
Active, not recruiting |
NCT03641300 -
Efficacy of Convulsive Therapies for Bipolar Depression
|
N/A | |
Not yet recruiting |
NCT04432116 -
Time and Virtual Reality in Schizophrenia and Bipolar Disorder
|
N/A | |
Terminated |
NCT02909504 -
Gao NARASD Lithium Study
|
Phase 4 | |
Completed |
NCT02970721 -
Use of Psychotropic Medications Among Pregnant Women With Bipolar Disorder
|
||
Terminated |
NCT02893371 -
Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
|
||
Recruiting |
NCT02481245 -
BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study
|
Phase 2 | |
Recruiting |
NCT03088657 -
Design and Methods of the Mood Disorder Cohort Research Consortium (MDCRC) Study
|